Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Medtronic
Moodys
US Army
McKesson
Farmers Insurance
Queensland Health
Healthtrust

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202357

« Back to Dashboard

NDA 202357 describes ATORVASTATIN CALCIUM, which is a drug marketed by Accord Hlthcare, Apotex Inc, Dr Reddys Labs Ltd, Invagen Pharms, Lannett Co Inc, Mylan Pharms Inc, Sandoz Inc, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Teva Pharms, and Teva Pharms Usa, and is included in twelve NDAs. It is available from fifty-eight suppliers. Additional details are available on the ATORVASTATIN CALCIUM profile page.

The generic ingredient in ATORVASTATIN CALCIUM is atorvastatin calcium. There are sixty-one drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the atorvastatin calcium profile page.
Summary for 202357
Tradename:ATORVASTATIN CALCIUM
Applicant:Dr Reddys Labs Ltd
Ingredient:atorvastatin calcium
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 202357
Medical Subject Heading (MeSH) Categories for 202357
Suppliers and Packaging for NDA: 202357
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 202357 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7772 N 0615-7772-05
ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 202357 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7772 N 0615-7772-39

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 80MG BASE
Approval Date:Jul 17, 2012TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Harvard Business School
Moodys
Argus Health
US Department of Justice
QuintilesIMS
Covington
Baxter
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.